Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Joshua Lawrence Roffman, M.D.

Co-Author

This page shows the publications co-authored by Joshua Roffman and Roy Perlis.
Connection Strength

0.555
  1. Hart KL, Brown HE, Roffman JL, Perlis RH. Risk tolerance measured by probability discounting among individuals with primary mood and psychotic disorders. Neuropsychology. 2019 Mar; 33(3):417-424.
    View in: PubMed
    Score: 0.224
  2. Brown HE, Hart KL, Snapper LA, Roffman JL, Perlis RH. Impairment in delay discounting in schizophrenia and schizoaffective disorder but not primary mood disorders. NPJ Schizophr. 2018 May 28; 4(1):9.
    View in: PubMed
    Score: 0.214
  3. Tseng CJ, Gilbert TM, Catanese MC, Hightower BG, Peters AT, Parmar AJ, Kim M, Wang C, Roffman JL, Brown HE, Perlis RH, Zürcher NR, Hooker JM. In vivo human brain expression of histone deacetylases in bipolar disorder. Transl Psychiatry. 2020 Jul 08; 10(1):224.
    View in: PubMed
    Score: 0.062
  4. Gilbert TM, Zürcher NR, Wu CJ, Bhanot A, Hightower BG, Kim M, Albrecht DS, Wey HY, Schroeder FA, Rodriguez-Thompson A, Morin TM, Hart KL, Pellegrini AM, Riley MM, Wang C, Stufflebeam SM, Haggarty SJ, Holt DJ, Loggia ML, Perlis RH, Brown HE, Roffman JL, Hooker JM. PET neuroimaging reveals histone deacetylase dysregulation in schizophrenia. J Clin Invest. 2019 01 02; 129(1):364-372.
    View in: PubMed
    Score: 0.055
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.